Read More Pharma Industry News Capricor Therapeutics announces promising long-term results for deramiocel deramiocel in Duchenne muscular dystrophy Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company at the forefront of developing cell and exosome-based therapies, has shared… byPallavi MadhirajuJune 29, 2024